VCEL Vericel Corp Ord

$37.03

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 8/22/2025

About Vericel Corp Ord

Vericel Corporation, a commercial-stage biopharmaceutical company, researches, develops, manufactures, and distributes cell therapies for the sports medicine and severe burn care markets in the United States. The company is headquartered in Cambridge, Massachusetts.

Website: https://www.vcel.com

Sector
LIFE SCIENCES
Industry
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
December
CIK
887359
Address
64 SIDNEY ST., CAMBRIDGE, MA, US
Valuation
Market Cap
$2.07B
P/E Ratio
206.15
PEG Ratio
0.00
Price to Book
7.08
Performance
EPS
$0.20
Dividend Yield
—
Profit Margin
4.37%
ROE
4.00%
Technicals
50D MA
$48.48
200D MA
$50.06
52W High
$63.00
52W Low
$37.76
Fundamentals
Shares Outstanding
50M
Target Price
$63.75
Beta
1.62

VCEL EPS Estimates vs Actual

● Estimated
● Actual

VCEL News & Sentiment

Aug 14, 2025 • Motley Fool SOMEWHAT-BULLISH
MediWound Revenue Jumps 43% in Q2
MediWound ( NASDAQ:MDWD ) reported fiscal second quarter 2025 results on Aug. 14, 2025, with revenue rising 43% quarter over quarter to $5.7 million, driven by higher product sales and a favorable mix. The company advanced its Phase III EscharEx VALUE trial, expanded NexoBrid's U.S. presence, and ...
Aug 14, 2025 • Motley Fool SOMEWHAT-BULLISH
MediWound ( MDWD ) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.Thursday, August 14, 2025 at 8:30 a.m. ETChief Executive Officer - Ofer GonenContinue reading ...
Aug 05, 2025 • Motley Fool SOMEWHAT-BULLISH
Vericel Q2 Revenue Jumps 20%
Vericel ( NASDAQ:VCEL ) , a cell therapy specialist focused on sports medicine and burn care, reported its Q2 2025 results on July 31, 2025. The most headline-worthy news was the 20% year-over-year GAAP revenue growth, driven strongly by its MACI franchise, and a substantial gross margin gain to ...
Jul 31, 2025 • Zacks Commentary NEUTRAL
Vericel Corporation ( VCEL ) Reports Q2 Loss, Lags Revenue Estimates
Vericel (VCEL) delivered earnings and revenue surprises of +75.00% and -1.33%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Jul 31, 2025 • GlobeNewswire NEUTRAL
Vericel Reports Second Quarter 2025 Financial Results
Total Revenue Growth of 20% to $63.2 Million, with MACI Revenue Growth of 21% to $53.5 Million ...
Jul 30, 2025 • Zacks Commentary NEUTRAL
Wave Life Sciences ( WVE ) Reports Q2 Loss, Misses Revenue Estimates
Wave Life Sciences (WVE) delivered earnings and revenue surprises of -6.90% and -31.16%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Sentiment Snapshot

Average Sentiment Score:

0.177
50 articles with scored sentiment

Overall Sentiment:

Bullish

VCEL Reported Earnings

Feb 26, 2025
Dec 31, 2024 (Pre market)
0.04 Surprise
  • Reported EPS: $0.38
  • Estimate: $0.34
  • Whisper: —
  • Surprise %: 11.8%
Nov 07, 2024
Sep 30, 2024 (Pre market)
0.03 Surprise
  • Reported EPS: $-0.02
  • Estimate: $-0.05
  • Whisper: —
  • Surprise %: 60.0%
Aug 01, 2024
Jun 30, 2024 (Pre market)
-0.02 Surprise
  • Reported EPS: $-0.10
  • Estimate: $-0.08
  • Whisper: —
  • Surprise %: -25.0%
May 08, 2024
Mar 31, 2024 (Pre market)
0.03 Surprise
  • Reported EPS: $-0.08
  • Estimate: $-0.11
  • Whisper: —
  • Surprise %: 27.3%
Feb 29, 2024
Dec 31, 2023 (Pre market)
0.09 Surprise
  • Reported EPS: $0.26
  • Estimate: $0.17
  • Whisper: —
  • Surprise %: 52.9%
Nov 08, 2023
Sep 30, 2023 (Pre market)
0.04 Surprise
  • Reported EPS: $-0.08
  • Estimate: $-0.12
  • Whisper: —
  • Surprise %: 33.3%
Aug 02, 2023
Jun 30, 2023 (Pre market)
0.04 Surprise
  • Reported EPS: $-0.11
  • Estimate: $-0.15
  • Whisper: —
  • Surprise %: 26.7%
May 10, 2023
Mar 31, 2023 (Pre market)
-0.01 Surprise
  • Reported EPS: $-0.16
  • Estimate: $-0.15
  • Whisper: —
  • Surprise %: -6.7%
Feb 23, 2023
Dec 31, 2022 (Pre market)
0.08 Surprise
  • Reported EPS: $0.12
  • Estimate: $0.04
  • Whisper: —
  • Surprise %: 200.0%

Financials